MENU
BBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BridgeBio Pharma (BBIO) Ownership - Who owns BridgeBio Pharma?
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases... Show more
Profile
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
556
Web
https://www.bridgebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.84B
P/E Ratio
N/A
Total Cash
681.1M
Projected Growth
N/A
Total Debt
1.73B
Revenue
221.9M
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash/Share
3.58
Total Debt/Equity
N/A
Revenue/Share
1.19 USD as % of share price
Fundamentals
BBIO
Capitalization
6.84B
P/E Ratio
N/A
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash
681M
Total Cash/Share
3.58
Total Debt
1.73B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.19%
Revenue
222M
ROE
N/A
Book Value
-1.47B
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
196K
Current Ratio
4.67
Current Revenue Per Employee
8057.53
Dividends Per Share - Security
N/A
EBITDA
-436.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
64.57
Revenue To Assets
-73.11
Shares Held By Institutions
9.11B
Shares Outstanding - Current
190M
Total Liabilities
2.38B
Total Volume MTD
N/A
Value
1
Gain YTD
31.050
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
556
Web
https://www.bridgebio.com